← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2001Last known activity
Jan 7, 2017
Acquired by Mylan on Aug 5, 2016
Timeline
Drugs by trial phase (23 distinct, 46 trials)
Phase 4 (8 own, 0 via acquisition)
Phase 3 (10 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Arthritis
- Arthritis, Rheumatoid
- Asthma
- Asthma, Exercise-Induced
- Atrial Fibrillation
- Back Pain
- Basal Cell Carcinoma
- Carcinoma
- Cervical Intraepithelial Neoplasia
- Common Cold
- Condylomata Acuminata
- Dermatitis
- Dermatitis, Atopic
- Diabetic Neuropathies
- Eczema
- Esophagitis
- Herpes Labialis
- Hutchinson's Melanotic Freckle
- Keratosis
- Keratosis, Actinic
- Lentigo
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Low Back Pain
- Melanoma
- Polyneuropathies
- Rhinitis
- Rhinitis, Allergic
- Rhinitis, Allergic, Perennial
- Rhinitis, Allergic, Seasonal
- Warts
Subsidiaries (2 direct, 3 total across the full acquisition tree)
Recent trials (50)
- NCT03004131Lead sponsorPhase 4Jan 7, 2017
- NCT03004131Study directorPhase 4Jan 7, 2017
- NCT02883439CollaboratorN/AAug 1, 2016
- NCT02404103CollaboratorN/AMar 1, 2015
- NCT02329171CollaboratorPhase 3Dec 1, 2014
- NCT01915823Lead sponsorPhase 3Jul 1, 2013
- NCT01880840Lead sponsorPhase 4Jun 1, 2013
- NCT01794741Lead sponsorPhase 3Feb 1, 2013
- NCT01720407CollaboratorPhase 3Dec 1, 2012
- NCT01574612Lead sponsorPhase 3Mar 1, 2012
- NCT01574612Study directorPhase 3Mar 1, 2012
- NCT01453179Study directorPhase 4Oct 1, 2011
- NCT01453179Lead sponsorPhase 4Oct 1, 2011
- NCT01336530Study chairPhase 3Apr 1, 2011
- NCT01336530Lead sponsorPhase 3Apr 1, 2011
Details
- Founded
- Solna, SE Jan 1, 2001
- Last known activity
- Jan 7, 2017
Notes
Acquired by Mylan 10 Feb 2016